NCT05024344View on ClinicalTrials.gov

ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy

NARecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Nephrolithotomy, Percutaneous
Interventions
PROCEDURE

Erector Spinae Plane Block

The Anesthesiologist will use ultrasound-guided technique and inject 30mL of 0.5% ropivacaine with 4 mg of dexamethasone or saline placebo control into the erector spinae muscle, superficial to the tips of the thoracic transverse processes

DRUG

Ropivacaine 0.5% Injectable Solution

The Anesthesiologist will use ultrasound-guided technique and inject 30mL of 0.5% ropivacaine with 4 mg of dexamethasone or saline placebo control into the erector spinae muscle, superficial to the tips of the thoracic transverse processes

DRUG

Dexamethasone

The Anesthesiologist will use ultrasound-guided technique and inject 30mL of 0.5% ropivacaine with 4 mg of dexamethasone or saline placebo control into the erector spinae muscle, superficial to the tips of the thoracic transverse processes

Trial Locations (1)

37920

RECRUITING

University of Tennessee Medical Center, Knoxville

All Listed Sponsors
lead

University of Tennessee Medical Center

OTHER